Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000935836-25-000719
Filing Date
2025-12-16
Accepted
2025-12-16 16:04:26
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 13627
2 AGREEMENT RE JOINT FILING stonepineex99.htm EX-99 4492
  Complete submission text file 0000935836-25-000719.txt   20070
Mailing Address 2900 NW CLEARWATER DRIVE SUITE 100-11 BEND OR 97703
Business Address 2900 NW CLEARWATER DRIVE SUITE 100-11 BEND OR 97703 541-647-5673
Stonepine Capital Management, LLC (Filed by) CIK: 0001440771 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G

Mailing Address 23 HATA'AS STREET KFAR SABA Israel 44425
Business Address 23 HATA'AS STREET KFAR SABA Israel 44425 97299741444
Quoin Pharmaceuticals, Ltd. (Subject) CIK: 0001671502 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3
Type: SCHEDULE 13G | Act: 34 | File No.: 005-89873 | Film No.: 251575136
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)